The life sciences industry needs a shot of adrenaline. An aging population and a rise in chronic diseases are fueling the ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company integrating artificial intelligence ...

Ten stocks took a beating on Wednesday, mimicking a mostly pessimistic broader market, as investors repositioned portfolios ...

How to get rich? The single best way is to live a long time, ideally working much of that time while amassing savings that ...

The U.S. is engaged in various activities from international deportation agreements to tackling AI-induced job fears. Notable developments include Google's $30 million settlement over YouTube's child ...

Recent reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and research funding in jeopardy.

The Global Mass Spectrometry Market size valued at approximately USD 6.9 billion in 2024, is projected to reach USD 10.38 billion by 2030, growing at ...

The European Union and the United States have published a joint statement, spelling out in writing the terms of the trade ...

With one year until new rules on ‘high-risk’ AI systems take effect in the EU, pharmaceutical companies using AI in the ...

The U.S. and European Union had first struck a trade agreement in July, but many details were left unresolved at the time.

Rob Abbott, CEO, ISPOR, highlights how AI is streamlining research and improving patient care while stressing the importance of human oversight.